Acneiform eruption / acneiform dermatitis / acneiform rash
- (2018): Shukla S+, Expert Opin Drug Saf 17(2), 179 [REVIEW]
- (2016): Nagesh TS+, Indian J Dermatol 61(6), 618
- (2019): Ah YM+, Basic Clin Pharmacol Toxicol Apr, Epub ahead of print
- (2018): Shukla S+, Expert Opin Drug Saf 17(2), 179 [REVIEW]
- (2015): Barnes L+, Drug Saf 38(5), 493 [REVIEW]
Burning / skin burning sensation
- (2016): Nagesh TS+, Indian J Dermatol 61(6), 618
Cutaneous adverse reaction (includes severe cutaneous adverse drug reaction (SCAR))
- (2017): Sharma R+, J Dermatol Case Rep 11(1), 5-8 (facial dermatoses)
- (2016): Nagesh TS+, Indian J Dermatol 61(6), 618
Pigmentation (Skin) (includes hyperpigmentation)
- (2019): Ah YM+, Basic Clin Pharmacol Toxicol Apr, Epub ahead of print
- (2018): Shukla S+, Expert Opin Drug Saf 17(2), 179 [REVIEW]
- (2016): Nagesh TS+, Indian J Dermatol 61(6), 618
- (2016): Nagesh TS+, Indian J Dermatol 61(6), 618
- (2021): El Jazouly M+, Clin Case Rep 9(4), 2507-2509 (1 case / female) (with phototherapy)
- (2025): Mochizuki A+, Exp Dermatol 34(3), e70084
- (2024): Kim TM+, Acta Derm Venereol 104, adv40045
- (2022): Katoch S+, Indian Dermatol Online J 13(3), 395-397 (1 case / female)
- (2018): Shukla S+, Expert Opin Drug Saf 17(2), 179 [REVIEW]
- (2016): Nagesh TS+, Indian J Dermatol 61(6), 618
- (2018): Shukla S+, Expert Opin Drug Saf 17(2), 179 [REVIEW]